Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Rhythm Pharmaceuticals gains on report of additional bidder (RYTM:NASDAQ)

Summary by Seeking Alpha
Rhythm Pharmaceuticals jumps on a reported second bidder after AstraZeneca’s near-$10B offer.

2 Articles

Seeking AlphaSeeking Alpha
Lean Right

Rhythm Pharmaceuticals gains on report of additional bidder (RYTM:NASDAQ)

Rhythm Pharmaceuticals jumps on a reported second bidder after AstraZeneca’s near-$10B offer.

·Ra'anana, Israel
Read Full Article
TokenPostTokenPost

Rhythm Pharmaceuticals Shares Rise 4.2% in Friday Trading

The gain followed a 22% rise by 4:13 p.m. ET Wednesday, Nov. 4.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Seeking Alpha broke the news in Ra'anana, Israel on Friday, November 6, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

AstraZeneca icon

AstraZeneca

United States icon

United States

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal